Effect of Structured Physical Activity on Inflammation and Immune Activation Profile of Antiretroviral Therapy-Experienced Children Living With HIV.


Journal

Pediatric exercise science
ISSN: 1543-2920
Titre abrégé: Pediatr Exerc Sci
Pays: United States
ID NLM: 8909729

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 21 05 2019
revised: 07 10 2019
accepted: 14 10 2019
entrez: 28 12 2019
pubmed: 28 12 2019
medline: 20 1 2021
Statut: ppublish

Résumé

To compare the markers of inflammation and immune activation in virally suppressed HIV-infected children on antiretroviral therapy, who practiced regular structured exercise comprising running and yoga to those who did not over a 2-year period. This retrospective cohort study included 72 children aged 8 to 16 years divided into 2 groups, exercisers (n = 36) and the nonexercisers (n = 36) based on their intentional physical activity. The analyses were carried out at baseline and after 2 years (Y2) for the soluble biomarkers of inflammation and immune activation (tumor necrosis factor alpha, interleukin-6, interleukin-10, interferon gamma, sCD14, and sCD163). In addition, cell-associated biomarker (CD38), lipopolysaccharides, and the gene expression of interleukin-2 and brain-derived neurotrophic factor were also measured at Y2. Reduction in levels of sCD14 (effect size [ES], -0.6; 95% confidence interval [CI], -1.08 to -0.14), tumor necrosis factor alpha (ES, -0.7; 95% CI, -1.18 to -0.23), interferon gamma (ES, -0.7; 95% CI, -1.17 to -0.22), and interleukin-10 (ES, -0.6; 95% CI, -1.08 to -0.14) was observed among exercisers as compared with nonexercisers at Y2. In addition, CD38+ expressing CD4+ T cells were found to be lower among exercisers (P = .01) at Y2. However, the differences in levels of interleukin-6, sCD163, lipopolysaccharides, interleukin-2, and brain-derived neurotrophic factor were not significantly different among the 2 groups. The study result suggests that regular structured physical activity improves the inflammatory profile of antiretroviral therapy-treated HIV-infected children.

Identifiants

pubmed: 31881531
doi: 10.1123/pes.2019-0126
pii: pes.2019-0126
doi:
pii:

Substances chimiques

Anti-HIV Agents 0
Biomarkers 0
Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-80

Auteurs

Bindu P Gopalan (BP)

St. John's National Academy of Health Sciences.
University of Trans-Disciplinary Health Sciences and Technology (TDU).

Mary Dias (M)

St. John's National Academy of Health Sciences.

Karthika Arumugam (K)

St. John's National Academy of Health Sciences.

Reena R D'Souza (RR)

St. John's National Academy of Health Sciences.

Mathew Perumpil (M)

Snehagram and Catholic Bishops' Conference of India.

Prasanna Kulkarni (P)

Institute of Ayurveda and Integrative Medicine (I-AIM) Healthcare Center.

Udaykumar Ranga (U)

Jawaharlal Nehru Centre for Advanced Scientific Research.

Anita Shet (A)

St. John's National Academy of Health Sciences.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH